Precision Therapeutics


Precision Therapeutics plans to launch new genomics product next year

Fresh off a $34 million Series D fundraise, Precision Therapeutics Inc. is planning to launch a “genomics” product sometime in 2011. CEO Sean McDonald offered few details beyond that, however. “All of our technology is geared toward helping patients and doctors understand which treatments are likely to be most effective based on [the cancer patient’s] […]


Precision Therapeutics raises $34M for personalized chemotherapy test

Precision Therapeutics Inc. has raised $34 million in equity and options to further develop a test that helps identify an individual’s best chemotherapy options, according to a filing with the Securities and Exchange Commission. The company’s ChemoFX drug marker tests multiple chemotherapies on a patient’s cancer cells before treatment to determine which drugs are likely […]